For a story in KFF Health News, she told Claire Sibonney that she has seen the lives of her adult patients change dramatically during research on this drug
Blood sugar headaches, sometimes called diabetic headaches, can easily be mistaken for Ozempic headaches
Making changes to your lifestyle is half the battle
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebocontrolled, dose-finding phase 2 trial
These conditions have been associated with kidney damage through metabolic, fibrotic, inflammatory, and hemodynamic mechanisms [54]
Darryl Leong, MBBs,MPH,PhD,FRACP,FESC Principal Investigator Population Health Research Institute and McMaster University Jehonathan Pinthus, MD,FRCS(C),PhD Principal Investigator Juravinski Cancer Centre Are You a Good Fit for This Trial